# Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

> clinical trial · VERIFIED · 2026-07-21

Status: RECRUITING · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) · Condition: Influenza Prevention

- Company: National Institute of Allergy and Infectious Diseases (NIAID)
- Sector: Influenza Prevention
- Primary source: https://clinicaltrials.gov/study/NCT06863142

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.